Hoffmann T C, Glasziou P P, Boutron I, Milne R, Perera R, Moher D, Altman D G, Barbour V, Macdonald H, Johnston M, Lamb S E, Dixon-Woods M, McCulloch P, Wyatt J C, Chan A-W, Michie S
Centre for Research in Evidence Based Practice, Faculty of Health Sciences and Medicine, Bond University, Queensland, Australia, 4229.
INSERMU738, Université Paris Descartes-Sorbonne Paris Cité, Paris, France.
Gesundheitswesen. 2016 Mar;78(3):175-88. doi: 10.1055/s-0041-111066. Epub 2016 Jan 29.
Without a complete published description of interventions, clinicians and patients cannot reliably implement interventions that are shown to be useful, and other researchers cannot replicate or build on research findings. The quality of description of interventions in publications, however, is remarkably poor. To improve the completeness of reporting, and ultimately the replicability, of interventions, an international group of experts and stakeholders developed the Template for Intervention Description and Replication (TIDieR) checklist and guide. The process involved a literature review for relevant checklists and research, a Delphi survey of an international panel of experts to guide item selection, and a face-to-face panel meeting. The resultant 12-item TIDieR checklist (brief name, why, what (materials), what (procedure), who intervened, how, where, when and how much, tailoring, modifications, how well (planned), how well (actually carried out)) is an extension of the CONSORT 2010 statement (item 5) and the SPIRIT 2013 statement (item 11). While the emphasis of the checklist is on trials, the guidance is intended to apply across all evaluative study designs. This paper presents the TIDieR checklist and guide, with a detailed explanation of each item, and examples of good reporting. The TIDieR checklist and guide should improve the reporting of interventions and make it easier for authors to structure the accounts of their interventions, reviewers and editors to assess the descriptions, and readers to use the information.
如果没有已发表的关于干预措施的完整描述，临床医生和患者就无法可靠地实施已被证明有用的干预措施，其他研究人员也无法复制或基于研究结果进行拓展。然而，出版物中对干预措施的描述质量非常差。为了提高干预措施报告的完整性，并最终提高其可复制性，一个国际专家和利益相关者小组制定了干预描述与复制模板（TIDieR）清单和指南。该过程包括对相关清单和研究进行文献综述、对国际专家小组进行德尔菲调查以指导项目选择，以及一次面对面的专家小组会议。由此产生的12项TIDieR清单（简短名称、原因、是什么（材料）、是什么（程序）、谁进行了干预、如何进行、在哪里、何时以及多少、定制、修改、计划得如何、实际执行得如何）是CONSORT 2010声明（第5项）和SPIRIT 2013声明（第11项）的扩展。虽然该清单的重点是试验，但该指南旨在适用于所有评估性研究设计。本文介绍了TIDieR清单和指南，并对每个项目进行了详细解释，还给出了良好报告的示例。TIDieR清单和指南应能改善干预措施的报告情况，使作者更容易构建其干预措施的描述，使审稿人和编辑更容易评估这些描述，也使读者更容易使用这些信息。
